NDA 040311 describes MEDROXYPROGESTERONE ACETATE, which is a drug marketed by
Amneal,
Amphastar Pharms Inc,
Cipla,
Eugia Pharma,
Hikma,
Hong Kong,
Sandoz,
Sun Pharm,
Teva Pharms Usa,
Xiromed,
Barr,
Duramed Pharms Barr, and
Upsher Smith Labs, and is included in sixteen NDAs. It is available from
twenty suppliers. Additional details are available on the
MEDROXYPROGESTERONE ACETATE profile page.
The generic ingredient in MEDROXYPROGESTERONE ACETATE is
medroxyprogesterone acetate. There are twenty
drug master file entries for this compound. Twenty-four
suppliers are listed for this compound. Additional details are available on the
medroxyprogesterone acetate profile page.